Currently, no clear guidance exists regarding the optimal duration of biologic therapy in asthma. This study retrospectively examined clinical outcomes following benralizumab discontinuation in patients with severe eosinophilic asthma. Nineteen patients classi... ...

请注册登录后继续浏览